Oneto v. Watson

CourtDistrict Court, N.D. California
DecidedNovember 18, 2022
Docket3:22-cv-05206
StatusUnknown

This text of Oneto v. Watson (Oneto v. Watson) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Oneto v. Watson, (N.D. Cal. 2022).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 ROY J ONETO, Case No. 3:22-cv-05206-WHO

8 Plaintiff, ORDER DENYING MOTION TO 9 v. REMAND

10 MELVIN WATSON, et al., Re: Dkt. No. 10 Defendants. 11

12 Plaintiff Roy Oneto filed this underlying action in state court, asserting several claims 13 against his insurance providers for failing to cover a medical operation. One named defendant, 14 Melvin Watson, removed the case to federal court. Oneto filed a motion to remand, asserting that 15 the removal was improper for various reasons but not contesting jurisdiction. None of the reasons 16 has merit, and his motion is denied. 17 BACKGROUND 18 Oneto’s initial complaint was filed on December 9, 2021, against Cigna Health and Life 19 Insurance Company, Cigna Health Management Inc., Melvin Watson, M.D., and Does 1 through 20 100. See Notice of Removal (“Rem.”) [Dkt. No. 1] Ex. A. Oneto sent Scott Klausner, attorney for 21 the Cigna entities, a courtesy copy of the complaint on December 10, 2021. See Motion to 22 Remand (“Mot.”) [Dkt. No. 10] Ex. 1. Oneto served Cigna Health and Life Insurance Company 23 and Cigna Health Management Inc. on February 2, 2022. Rem. Exs. C, D. 24 On March 21, 2022, Klausner said in an email to Oneto’s counsel, “I have concerns about 25 the claims asserted against Dr. Watson individually.” Mot. Ex. 3. In a separate email that day he 26 acknowledged his firm represented the Cigna entities and said, “I imagine we will also represent 27 Dr. Watson, but I don’t have that confirmed yet. . . . I’ll have to await confirmation regarding our 1 Oneto’s counsel that he was “still waiting on word” with respect to whether his firm would 2 represent Watson. Opposition to Remand (“Oppo.”) [Dkt. No. 12] Ex. 1. 3 On April 25, 2022, Oneto served Klausner via an amended complaint, substituting in 4 Cigna Healthcare of Texas, Inc. (“Cigna Texas”), and “Melvin Watson in his capacity as Cigna 5 Healthcare of Texas Vice President and Medical Director.” Mot. Ex. 4-5. The following day, 6 Klausner sent an email to Oneto’s counsel saying, “I don’t understand the substitution of Dr. 7 Watson for Doe 31. Dr. Watson was named as a defendant in the original complaint, so he’s 8 already a party.” Oppo. Ex. 1. Oneto’s attorney responded, “The amendments address your 9 concern regarding the suit against Dr. Watson as an ‘individual.’” Id. Klausner replied, “I’m not 10 sure I follow. It seems to me that you’ve now sued the same defendant twice,” and then: “In any 11 event, it looks like Dr. Watson may have separate counsel and will not be represented by 12 [Klausner’s firm] Cole Pedroza. I’ll confirm shortly once a final decision is made.” Id. 13 Klausner informed Oneto’s counsel via email on May 3, 2022, that Watson would have 14 alternative representation. Oppo. Ex. 1. 15 On August 4, 2022, Cigna Texas was served. Mot. Ex. 6. And on August 13, 2022, 16 “Melvin Watson, MD., VP-Medical Director for Cigna Healthcare of Texas, Inc.” was served with 17 the summons, complaint, exhibits, amended complaint, notice of remot appearance, and notice of 18 intent to sue. Mot. Ex. 7 at Crisp Ex. 2; see also Mot. Ex. 7 ¶¶ 4-5 (stating Watson was served “as 19 the ‘Agent for service of process’ on behalf of Melvin Watson, MD., VP-Medical Director for 20 Cigna Healthcare of Texas, Inc.”). 21 On September 8, 2022, Watson filed an answer in state court, see Mot. 4:3-7, and four days 22 later removed the case to federal court. See Rem. On October 10, 2022, Oneto filed this motion 23 to remand, see Mot. Under Civil Local Rule 7-1(b), I found this matter appropriate for resolution 24 without oral argument and vacated the hearing scheduled for November 21, 2022. See Dkt. No. 25 14. 26 LEGAL STANDARD 27 Generally, a case can only be removed from state to federal court when the federal court 1 federal diversity jurisdiction exists when each plaintiff is a citizen of a different state from each 2 defendant and the amount in controversy exceeds $75,000. Natural persons are the citizens of the 3 state in which they are domiciled—that is, the state in which they reside with intent to remain 4 permanently. See Kanter v. Warner-Lambert Co., 265 F.3d 853, 857 (9th Cir. 2001). 5 “[R]emoval statutes should be construed narrowly in favor of remand to protect the 6 jurisdiction of state courts.” Cnty. of San Mateo v. Chevron Corp., 32 F.4th 733, 764 (9th Cir. 7 2022) (quoting Harris v. Bankers Life and Cas. Co., 425 F.3d 689, 698 (9th Cir. 2005)). “The 8 defendant has the burden of proving by a preponderance of the evidence that the requirements for 9 removal jurisdiction have been met.” Id. at 746 (citing Leite v. Crane Co., 749 F.3d 1117, 1122 10 (9th Cir. 2014)). Removability is “generally determined as of the time of the petition for 11 removal.” Local Union 598, Plumbers & Pipefitters Indus. Journeymen & Apprentices Training 12 Fund v. J.A. Jones Constr. Co., 846 F.2d 1213, 1215 (9th Cir. 1988). 13 As relevant here, 28 U.S.C. § 1446(b)(1) provides that a “notice of removal of a civil 14 action or proceeding shall be filed . . . within 30 days after the service of summons upon the 15 defendant.” 16 DISCUSSION 17 As a preliminary matter, Oneto does not contest that I have diversity jurisdiction over this 18 case, given that the amount in controversy is over $75,000 and he is a citizen of California while 19 Watson is a citizen of Georgia, Cigna Texas is a citizen of Texas, and the other two Cigna entities 20 are citizens of Connecticut. See Rem. ¶ 7; 28 U.S.C. § 1332(a). Rather, he asserts that removal 21 was improper for three reasons. None is convincing. I address each in turn. 22 I. Diversity Based on the Face of the Complaint 23 Oneto first argues that the case was improperly removed to federal court because no facts 24 “on the face of the complaint” support diversity jurisdiction since there are no facts showing 25 Watson’s domicile. Mot. 4:14-6:13. This argument lacks merit. 26 As the defendants point out, Oneto selectively cites portions of Harris v. Bankers Life and 27 Casualty Company, 425 F.3d 689 (9th Cir. 2005), as support for his argument. The Ninth Circuit 1 service of the complaint if the facts of diversity are not clear on the face of the complaint. Id. at 2 694-96. In other words, Harris stands for the proposition that the thirty-day period for removal 3 does not begin to run unless the basis of diversity citizenship is clear on the face of the complaint, 4 but it does not preclude a defendant from removing the complaint based on additional 5 investigation to confirm the basis for removal. This interpretation was confirmed by the Ninth 6 Circuit in Roth v. Hollywood Medical Center, L.P., which explained: 7 Harris did not address a case in which a defendant conducted its own investigation, even though not required to do so, and discovered that a case was removable. We 8 conclude that [28 U.S.C.] §§ 1441 and 1446, read together, permit a defendant to remove outside the two thirty-day periods on the basis of its own information, 9 provided that it has not run afoul of either of the thirty-day deadlines. . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Shanna Kuxhausen v. Bmw Financial Services Na Llc
707 F.3d 1136 (Ninth Circuit, 2013)
Amy Roth v. Cha Hollywood Medical Center
720 F.3d 1121 (Ninth Circuit, 2013)
Douglas Leite v. Crane Company
749 F.3d 1117 (Ninth Circuit, 2014)
County of San Mateo v. Chevron Corp.
32 F.4th 733 (Ninth Circuit, 2022)

Cite This Page — Counsel Stack

Bluebook (online)
Oneto v. Watson, Counsel Stack Legal Research, https://law.counselstack.com/opinion/oneto-v-watson-cand-2022.